Lv1
28 积分 2022-08-16 加入
Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma
1个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已完结
Promises and potential pitfalls of in vivo CAR gene therapy
1个月前
已完结
Promises and potential pitfalls of in vivo CAR gene therapy
1个月前
已完结
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
5个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
6个月前
已完结
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
6个月前
已完结
International approvals of cilta-cel: a lens on CAR T cell regulation
6个月前
已完结
CAR-T cells: the Chinese experience
6个月前
已完结
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
10个月前
已完结
皖公网安备34019202002308
